The effects of fresh frozen plasma on cholinesterase levels and outcomes in patients with organophosphate poisoning

Journal of Toxicology - Clinical Toxicology

Volumn 42, Issue 5, 2004, Pages 617-623

  Güven, Muhammet ^a   Sungur, Murat ^a   Eser, Bülent ^a   Sari, Ismail ^a   Altuntaş, Fevzi ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Atropine; Fresh frozen plasma; Intermediate syndrome; Organophosphate; Poisoning; Pralidoxime

Indexed keywords

ATROPINE; CHOLINESTERASE; FRESH FROZEN PLASMA; ORGANOPHOSPHATE; PRALIDOXIME;

ADJUVANT THERAPY; CHOLINESTERASE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; INFORMED CONSENT; INTENSIVE CARE; INTERMEDIATE SYNDROME; INTOXICATION; MEDICATION ERROR; MORTALITY; OUTCOMES RESEARCH; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SYNDROME DELINEATION; TURKEY (REPUBLIC); UNIVERSITY HOSPITAL;

ATROPINE; BUTYRYLCHOLINESTERASE; CHOLINESTERASE REACTIVATORS; HUMANS; LENGTH OF STAY; MUSCARINIC ANTAGONISTS; ORGANOPHOSPHORUS COMPOUNDS; PLASMA; PRALIDOXIME COMPOUNDS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

ANIMALIA;

EID: 4644290841     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.1081/CLT-200026967     Document Type: Conference Paper

References (37)

1. Eddleston M. Patterns and problems of deliberate self-poisoning in the developing world. Q J Med 2002; 93(11):715-731.
2. Eddleston M, Szinicz L, Eyer P, Buckley N. Oximes in acute organophosphorus pesticide poisoning: a systematic review of clinical trials. Q J Med 2002; 95(5):275-283.
3. Sivagnanam S. Potential therapeutic agents in the management of organophosphorus poisoning. Crit Care 2002; 6(3):260-261.
4. de Silva HJ, Wijewickrema R, Senanayake N. Does pralidoxime affect outcome of management in acute organophosphorus poisoning? Lancet 1992; 339(8802):1136-1138.
5. Sudakin DL, Mullins ME, Horowitz BZ, Abshier V, Letzig L. Intermediate syndrome after malathion ingestion despite continuous infusion of pralidoxime. J Toxicol Clin Toxicol 2000; 38(1):47-50.
6. Johnson MK, Jacobsen D, Meredith TJ, Eyer P, Heath AJ, Ligtenstein DA, Marrs TC, Szinicz L, Vale JA, Haines JA. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Med 2000; 12:22-37.
7. Masson P, Froment MT, Bartels CF, Lockridge O. Importance of aspartate-70 in organophosphate inhibition, oxime re-activation and aging of human butyrylcholinesterase. Biochem J 1997;325(Pt. 1): 53-61.
8. Lallement G, Baille V, Baubichon D, Carpentier P, Collombet JM, Filliat P, Foquin A, Four E, Masqueliez C, Testylier G, Tonduli L, Dorandeu F. Review of the value of huperzine as pretreatment of organophosphate poisoning. Neurotoxicology 2002; 23(1):1-5.
9. Clair P, Wiberg K, Granelli I, Carlsson Bratt I, Blanchet G. Stability study of a new antidote drug combination (Atropine-HI-6-Prodiazepam) for treatment of organophosphate poisoning. Eur J Pharm Sci 2000; 9(3):259-263.
10. Sungur M, Guven M. Intensive care management of organophosphate insecticide poisoning. Crit Care 2001; 5(4):211-215.
11. Caranto GR, Waibel KH, Asher JM, Larrison RW, Brecht KM, Schutz MB, Raveh L, Ashani Y, Wolfe AD, Maxwell DM, Doctor BP. Amplification of the effectiveness of acetylcholinesterase for detoxification of organophosphorus compounds by bis-quaternary oximes. Biochem Pharmacol 1994; 47(2):347-357.
12. Ashani Y, Shapira S, Levy D, Wolfe AD, Doctor BP, Raveh L. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochem Pharmacol 1991; 41(1):37-41.
13. Raveh L, Grauer E, Grunwald J, Cohen E, Ashani Y. The stoichiometry of protection against soman and VX toxicity in monkeys pretreated with human butyrylcholinesterase. Toxicol Appl Pharmacol 1997; 145(1):43-53.
14. Ashani Y. Prospective of human butyrilcholinesterase as a detoxifying antidote and potential regulator of controlled-release drugs. Drug Dev Res 2000; 50:298-308.
15. Epstein HM, Jarzemsky D, Zuckerman L, Vagher P. Plasma cholinesterase activity in bank blood. Anesth Analg 1980; 59(3):211-214.
16. Ostergaard D, Viby-Mogensen J, Hanel HK, Skovgaard LT. Half-life of plasma cholinesterase. Acta Anaesthesiol Scand 1988; 32(3):266-269.
17. Guven M, Sungur M, Tanriverdi M, Eser B, Kekec Z. Evaluation of the patients with acute intoxication. Turk J Med Sci 2002; 32:169-172.
18. Khan S, Hemalatha R, Jeyaseelan L, Oommen A, Zachariah A. Neuroparalysis and oxime efficacy in organophosphate poisoning: a study of butyrylcholinesterase. Hum Exp Toxicol 2001; 20(4): 169-174.
19. De Bleecker JL. The intermediate syndrome in organophosphate poisoning: an overview of experimental and clinical observations. J Toxicol Clin Toxicol 1995; 33(6):683-686.
20. Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. N Engl J Med 1987; 316(13):761-763.
21. Karalliedde L. Organophosphorus poisoning and anaesthesia. Anaesthesia 1999; 54:1073-1088.
22. Johnson S, Peter JV, Thomas K, Jeyaseelan L, Cherian AM. Evaluation of two treatment regimens of pralidoxime (1 gm single bolus dose vs. 12 gm infusion) in the management of organophosphorus poisoning. J Assoc Phys India 1996; 44(8):529-531.
23. Cherian AM, Peter JV, Samuel J, Jaydevan R, Peter S, Joel S, Jeyaseelan L, Thomas K. Effectivenes of 2PAM (PAM-Pralidoxime) in the treatment of organophosphorus poisoning: a randomized double-blind, placebo-controlled clinical trial. J Assoc Phys India 1997; 45:22-24.
24. Kwong TC. Organophosphate pesticides: biochemistry and clinical toxicology. Ther Drug Monit 2002; 24:144-149.
25. Kassa J. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 2002; 40:803-816.
26. Aygun D, Doganay Z, Altintop L, Guven H, Onar M, Deniz T, Sunter T. Serum acetylcholinesterase and prognosis of acute organophosphate poisoning. J Toxicol Clin Toxicol 2002; 40:903-910.
27. Guven M, Dogukan A, Taskapan H, Çetin M. Leucocytosis as a parameter in management of organophosphate intoxication. Turk J Med Sci 2000; 30:499-500.
28. Raveh L, Grunwald J, Marcus D, Papier Y, Cohen E, Ashani Y. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity: in vitro and in vivo quantitative characterization. Biochem Pharmacol 1993; 45:2465-2474.
29. Broomfield CA, Maxwell DM, Solana RP, Castro CA, Finger AV, Lenz DE. Protection by butyrylcholinesterase against organophosphorus poisoning in nonhuman primates. J Pharmacol Exp Ther 1991; 259:633-638.
30. Grunwald J, Marcus D, Papier Y, Raveh L, Pittel Z, Ashani Y. Large-scale purification and long-term stability of human butyrylcholinesterase: a potential bioscavenger drug. J Biochem Biophys Methods 1997; 34:123-135.
31. Li B, Stribley JA, Ticu A, Xie W, Schopfer LM, Hammond P, Brimijoin S, Hinrichs SH, Lockridge O. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem 2000; 75:1320-1331.
32. Sams C, Mason HJ. Detoxification of organophosphates by A-esterases in human serum. Hum Exp Toxicol 1999; 18(11):653-658.
33. Dettbarn WD, Yang ZP, Milatovic D. Different role of carboxylesterases in toxicity and tolerance to paraoxon and DFP. Chem Biol Interact 1999; 120:445-454.
34. Jenkins T, Balinsky D, Patient DW. Cholinesterase in plasma: first reported absence in the Bantu half-life determination. Science 1967; 156:1748-1750.
35. Garry PJ, Prince LC, Notari RE. Half-life human serum cholinesterase following blood transfusion. Res Commun Chem Pathol Pharmacol 1974; 8:371-380.
36. Smith DC, Ridley SA, Donaldson KF. Fresh frozen plasma and edrophonium in a patient with a plasma cholinesterase deficiency. Anaesthesia 1993; 48:511-513.
37. Zhong P, Wang Q, Sheng H. Alteration of banked blood cholinesterase level and its significance in emergency treatment of acute organophosphorus pesticide poisoning. Zhonghua Nei Ke Za Zhi 2000; 39(10):658-659.